FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280541339> ?p ?o ?g. }

• W4280541339 endingPage "1019" @default.
• W4280541339 startingPage "1009" @default.
• W4280541339 abstract "Abstract Patients aged &lt;65 years with peripheral T-cell lymphoma (PTCL) are treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Although the addition of etoposide (CHOEP) and consolidation with autologous stem cell transplantation (ASCT) are preferred in some countries, randomized trials are lacking. This nationwide population-based study assessed the impact of etoposide and ASCT on overall survival (OS) among patients aged 18 to 64 years with stage II to IV anaplastic large-cell lymphoma (ALCL), angioimmunoblastic T-cell lymphoma (AITL), or PTCL not otherwise specified (NOS) diagnosed between 1989 and 2018 using the Netherlands Cancer Registry. Patients were categorized into 2 calendar periods, representing pre- and post-eras of etoposide and ASCT, respectively. A total of 1427 patients were identified (ALCL, 35%; AITL, 21%; and PTCL NOS, 44%). OS increased from 39% in the period from 1989 to 2009 to 49% in the period of 2009 to 2018 (P &lt; .01). Five-year OS was superior for patients treated with CHOEP vs CHOP (64% and 44%, respectively; P &lt; .01). When adjusted for subtype, International Prognostic Index score, and ASCT, the risk of mortality was similar between the 2 groups, except for patients with ALK+ ALCL, for whom the risk of mortality was 6.3 times higher when treated with CHOP vs CHOEP. Patients undergoing consolidation with ASCT had superior 5-year OS of 81% compared with 39% for patients not undergoing ASCT (P &lt; .01), regardless of whether complete remission was achieved. In patients aged &lt;65 years with advanced-stage ALK− ALCL, AITL, or PTCL, the use of ASCT consolidation, but not the addition of etoposide, was associated with improved OS." @default.
• W4280541339 created "2022-05-22" @default.
• W4280541339 creator A5024047541 @default.
• W4280541339 creator A5027593338 @default.
• W4280541339 creator A5033586033 @default.
• W4280541339 creator A5036293139 @default.
• W4280541339 creator A5038628139 @default.
• W4280541339 creator A5046812038 @default.
• W4280541339 creator A5050671882 @default.
• W4280541339 creator A5059491294 @default.
• W4280541339 creator A5062464380 @default.
• W4280541339 creator A5062523091 @default.
• W4280541339 creator A5065546672 @default.
• W4280541339 creator A5068092554 @default.
• W4280541339 creator A5070138739 @default.
• W4280541339 creator A5073166528 @default.
• W4280541339 creator A5086644689 @default.
• W4280541339 date "2022-09-01" @default.
• W4280541339 modified "2023-10-06" @default.
• W4280541339 title "Impact of etoposide and ASCT on survival among patients aged &lt;65 years with stage II to IV PTCL: a population-based cohort study" @default.
• W4280541339 cites W2006718553 @default.
• W4280541339 cites W2021464413 @default.
• W4280541339 cites W2037452407 @default.
• W4280541339 cites W2074643584 @default.
• W4280541339 cites W2098666639 @default.
• W4280541339 cites W2108465006 @default.
• W4280541339 cites W2116639751 @default.
• W4280541339 cites W2119015188 @default.
• W4280541339 cites W2162389158 @default.
• W4280541339 cites W2163510906 @default.
• W4280541339 cites W2168509026 @default.
• W4280541339 cites W2171873783 @default.
• W4280541339 cites W2416844197 @default.
• W4280541339 cites W2560307065 @default.
• W4280541339 cites W2600827940 @default.
• W4280541339 cites W2612780570 @default.
• W4280541339 cites W2772570340 @default.
• W4280541339 cites W2800172735 @default.
• W4280541339 cites W2801119848 @default.
• W4280541339 cites W2903308035 @default.
• W4280541339 cites W2913753524 @default.
• W4280541339 cites W2922545567 @default.
• W4280541339 cites W2982160098 @default.
• W4280541339 cites W2982903806 @default.
• W4280541339 cites W2983224080 @default.
• W4280541339 cites W3022107593 @default.
• W4280541339 cites W3026090978 @default.
• W4280541339 cites W3095719715 @default.
• W4280541339 cites W3114319385 @default.
• W4280541339 cites W3217609143 @default.
• W4280541339 doi "https://doi.org/10.1182/blood.2021015114" @default.
• W4280541339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35544601" @default.
• W4280541339 hasPublicationYear "2022" @default.
• W4280541339 type Work @default.
• W4280541339 citedByCount "21" @default.
• W4280541339 countsByYear W42805413392022 @default.
• W4280541339 countsByYear W42805413392023 @default.
• W4280541339 crossrefType "journal-article" @default.
• W4280541339 hasAuthorship W4280541339A5024047541 @default.
• W4280541339 hasAuthorship W4280541339A5027593338 @default.
• W4280541339 hasAuthorship W4280541339A5033586033 @default.
• W4280541339 hasAuthorship W4280541339A5036293139 @default.
• W4280541339 hasAuthorship W4280541339A5038628139 @default.
• W4280541339 hasAuthorship W4280541339A5046812038 @default.
• W4280541339 hasAuthorship W4280541339A5050671882 @default.
• W4280541339 hasAuthorship W4280541339A5059491294 @default.
• W4280541339 hasAuthorship W4280541339A5062464380 @default.
• W4280541339 hasAuthorship W4280541339A5062523091 @default.
• W4280541339 hasAuthorship W4280541339A5065546672 @default.
• W4280541339 hasAuthorship W4280541339A5068092554 @default.
• W4280541339 hasAuthorship W4280541339A5070138739 @default.
• W4280541339 hasAuthorship W4280541339A5073166528 @default.
• W4280541339 hasAuthorship W4280541339A5086644689 @default.
• W4280541339 hasBestOaLocation W42805413391 @default.
• W4280541339 hasConcept C126322002 @default.
• W4280541339 hasConcept C141071460 @default.
• W4280541339 hasConcept C2776694085 @default.
• W4280541339 hasConcept C2776755627 @default.
• W4280541339 hasConcept C2777872185 @default.
• W4280541339 hasConcept C2778119113 @default.
• W4280541339 hasConcept C2778476033 @default.
• W4280541339 hasConcept C2778720950 @default.
• W4280541339 hasConcept C2779050716 @default.
• W4280541339 hasConcept C2779338263 @default.
• W4280541339 hasConcept C2779429289 @default.
• W4280541339 hasConcept C2779725641 @default.
• W4280541339 hasConcept C2908647359 @default.
• W4280541339 hasConcept C71924100 @default.
• W4280541339 hasConcept C90924648 @default.
• W4280541339 hasConcept C99454951 @default.
• W4280541339 hasConceptScore W4280541339C126322002 @default.
• W4280541339 hasConceptScore W4280541339C141071460 @default.
• W4280541339 hasConceptScore W4280541339C2776694085 @default.
• W4280541339 hasConceptScore W4280541339C2776755627 @default.
• W4280541339 hasConceptScore W4280541339C2777872185 @default.
• W4280541339 hasConceptScore W4280541339C2778119113 @default.
• W4280541339 hasConceptScore W4280541339C2778476033 @default.
• W4280541339 hasConceptScore W4280541339C2778720950 @default.

• next